Watch for signs of low blood sugar (hypoglycemia), changes in appetite patterns, and digestive changesreport these to your healthcare provider immediately
[DOI] [PubMed] [Google Scholar] 14.Giulivi C., Cadenas E
FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Products The FDA announced plans to take action to restrict the use of glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredients in nonFDA-approved compounded drugs that are being mass-marketed as alternatives to approved products, including those by companies such as Hims & Hers and certain compounding pharmacies
By integrating psychological expertise into the management of GLP-1 RA therapy, ReadyMind ensures that patients are well-prepared and supported, maximising the potential benefits of treatment while mitigating risks.
But if your prescribing physician hasnt spoken to you about contraception before going on Mounjaro, make sure you initiate those conversations
10.1080/15548627.2022.2046457 118 Sancho-BruP.AltamiranoJ.Rodrigo-TorresD.CollM.MillanC.Jose LozanoJ.et al (2012)
